| 000 | 01277 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517230937.0 | ||
| 264 | 0 | _c20190708 | |
| 008 | 201907s 0 0 chi d | ||
| 022 | _a1007-8738 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDai, Jimin | |
| 245 | 0 | 0 |
_a[Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. _h[electronic resource] |
| 260 |
_bXi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology _cMay 2018 |
||
| 300 |
_a427-433 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aSorafenib _xpharmacology |
| 700 | 1 | _aNiu, Kunwei | |
| 700 | 1 | _aWang, Bo | |
| 700 | 1 | _aLi, Yijie | |
| 700 | 1 | _aXia, Congcong | |
| 700 | 1 | _aTao, Kaishan | |
| 700 | 1 | _aDai, Jingyao | |
| 773 | 0 |
_tXi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology _gvol. 34 _gno. 5 _gp. 427-433 |
|
| 999 |
_c28667295 _d28667295 |
||